MOUNTAIN VIEW, Calif., June 8 /PRNewswire-FirstCall/ -- IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care, announced today that CentraState Medical Center, a full-service community medical center in Freehold, New Jersey, is using IMPAC’s treatment management solution to sequence radiation therapy treatments on Varian Medical Systems’ 4D Integrated Treatment Console Clinac(R). CentraState is one of several centers where IMPAC’s treatment management solution is in routine clinical use with the Varian 4D Console.
CentraState recently converted to IMPAC in order to transition their center to full image-enabled charting and practice management, and in May of 2005 they upgraded their Varian accelerator to the 4D treatment console to support Varian’s On-Board Imager(TM) (OBI). According to Jan Dragotta, clinical director of radiation oncology, “We were already planning to implement Varian’s 4D Console and OBI when we decided to convert to the IMPAC system, so IMPAC’s proven support of the new image-guided technology was critical. I was impressed by how smoothly we were able to make the transition to the 4D. It’s less than a month and we’re already treating 30 patients a day and our productivity continues to improve.
“IMPAC’s commitment to our customers drives us to provide leading-edge clinical capabilities in an open-architecture environment supporting multiple equipment manufacturers,” stated Joseph K. Jachinowski, president and CEO of IMPAC Medical Systems. “The development efforts devoted to image guided radiotherapy (IGRT) demonstrate our dedication to providing the best oncology information management system capable of supporting any combination of treatment planning and delivery equipment our customers may choose, including Elekta Synergy(R) and Varian’s On-Board Imager.”
“With 30% of our patients being treated with Intensity Modulated Radiotherapy (IMRT) and therefore requiring pre-port setup fields, we’re looking forward to implementing OBI and manipulating and storing images as part of IMPAC’s image-enabled oncology chart,” said Dragotta. “We appreciate the value of an independent verification solution which provides us with choice and flexibility in our equipment purchases.”
For more information, please contact: Julie DeSantis, Public Relations Manager IMPAC Medical Systems, Inc. Tel: +1 650-623-8883, e-mail: jdesantis@impac.com Investor Enquiries: International: Peter Ejemyr, Group VP Corporate Communications, Elekta AB Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com United States: Lars Jonsteg, VP Investor Relations North America, Elekta Inc. Tel: +46 708-783 735, e-mail: lars.jonsteg@elekta.com About IMPAC Medical Systems
IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC’s products or services, please call 888-GO-IMPAC or visit www.impac.com.
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. With approx. 1700 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta’s products or services, please visit www.elekta.com.
IMPAC Medical Systems, Inc.
CONTACT: Julie DeSantis, Public Relations Manager of IMPAC MedicalSystems, Inc., +1-650-623-8883, or jdesantis@impac.com; or investors,International, Peter Ejemyr, Group VP Corporate Communications of ElektaAB, +46-733-611-000, or peter.ejemyr@elekta.com; or U.S., Lars Jonsteg, VPInvestor Relations North America of Elekta Inc., +46-708-783-735, orlars.jonsteg@elekta.com